ArticleEuropean journal of radiology open2025
Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) for ablation of osteoid osteoma: Long-term results from 10 years of experience.
Article in European journal of radiology open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoid Osteoma (OO) is a benign but extremely painful bone lesion, mostly treated using Radiofrequency Ablation with needle (RFA). Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) is an alternative technique able to ablate without using needles or skin incisions. Given the scarcity of literature in this field, the purpose of this paper is to retrospectively analyze long-term results of MRgFUS treatments of OO and to investigate technical limits. This is a retrospective analysis of all the MRgFUS procedures performed in our institution to treat OOs. Demographic, clinical data, and morphological features were analyzed, looking for correlation between the clinical results and the morphological features. Sixty-seven procedures were analyzed. The success rate - intended as complete pain relief - was 91 %. Almost all the patients (60 out of 67) were followed up to 4 years. A thick bone cortex above the nidus (p.014) and a short distance between the nidus and the ultrasound source (p.002) were statistically linked to failure. No complications were recorded. This is the largest series of OO treated using MRgFUS even reported. The main strength of this study lies in its large sample size and the extended follow-up period for nearly all patients (4 years for 90 % of patients) which allow us to clearly confirm the safety and efficacy of this ablative technique. Moreover, exclusion criteria for this treatment modality are proposed, based on two causes of treatment failure identified during our procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.